The arrival last March of the COVID-19 pandemic in Tennessee presented challenges for the clinical research enterprise at Vanderbilt University Medical Center. Prompt recruitment of patients newly diagnosed with COVID-19 into clinical trials was, and remains, a public health imperative with top-level backing from the federal government.
Paul Harris, PhD, FACMI, FIAHSI, Professor of Biomedical Informatics, Biomedical Engineering, and Biostatistics and Director of the Vanderbilt University Medical Center Office of Research Informatics, is quoted.
Read more in the VUMC Reporter here.